logo

Shariah compliance overview

Not Halal

Tango Therapeutics, Inc. (TNGX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Tango Therapeutics, Inc.

Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5).

Tango Therapeutics, Inc. (TNGX) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Business Activity.

Business Activity
8.28%Limit 5%Fail
Interest-bearing debt
2.41%Limit 30%Pass
Interest-bearing securities and assets
26.77%Limit 30%Pass
Dividend purification
8.28%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Tango Therapeutics, Inc. (TNGX). Current Akinda screening label: Not Halal.